Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.

Bibliographic Details
Main Authors:	Mehta, Z, Manley, S, Zimmett, P, Bottazzo, G, Cull, C, Holman, R, Turner, R, Grp, U
Format:	Journal article
Published:	1999

Similar Items

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
by: Turner, R, et al.
Published: (1997)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
by: Davis, T, et al.
Published: (2005)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
by: Clark, A, et al.
Published: (2005)

Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
by: Chang, T, et al.
Published: (2013)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
by: Stagg, C, et al.
Published: (2010)

SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
by: Stagg, C, et al.
Published: (2009)

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.
by: Davis, T, et al.
Published: (2003)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (1999)

Autoantibodies to islet amyloid polypeptide in diabetes.
by: Clark, A, et al.
Published: (1991)

The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
by: Muzaimi, M, et al.
Published: (2004)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
by: Turner, R, et al.
Published: (1998)

Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
by: Mirabelli-Badenier, M, et al.
Published: (2012)

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
by: Antozzi, C, et al.
Published: (2005)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
by: Horton, V, et al.
Published: (1999)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
by: Horton, V, et al.
Published: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)

Purification and characterization of glutamate decarboxylase from Aspergillus oryzae NSK
by: Lee, Audrey Ying Yeng
Published: (2014)

Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics
by: Nazaimoon, W.M.W., et al.
Published: (1999)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
by: Turner, R, et al.
Published: (1991)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
by: Manley, SE, et al.
Published: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
by: Cull, C, et al.
Published: (1993)

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
by: Malter, M, et al.
Published: (2010)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
by: MacNamara, C, et al.
Published: (2000)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
by: Adler, A, et al.
Published: (2003)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)

ISLET CELL AUTOANTIBODIES - WHICH METHOD
by: Clark, A, et al.
Published: (1983)

Autoantibodies to JA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes
by: Bosi, E, et al.
Published: (2001)

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
by: Honnorat, J, et al.
Published: (2001)

Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies
by: McGinty, R
Published: (2021)

Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families.
by: Gaughran, F, et al.
Published: (2005)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
by: Adler, A, et al.
Published: (2000)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
by: Stratton, I, et al.
Published: (2000)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)